David Levy, MD, FRCP Insulin Pump Treatment (CSII) First used at the end of the 1970s, insulin pump therapy is standard treatment for type 1 diabetes, although use varies between countries (e.g. about 1–2% in the UK, probably more now; about 25% in USA, up to 40% in Norway). Only rapid-acting …
Read More »‘Smart’ Insulin Holds Promise for Type 1 Diabetes Patients
A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes… Self-administered insulin is the most important therapeutic to provide control over blood glucose levels for patients with type 1 diabetes. However, standard insulin therapy introduces a …
Read More »Breastfeeding May Lower Risk of Type 1 Diabetes
A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes… The objective of this study was to determine the association of breast feeding duration with the risk of type 1 diabetes in genetically predisposed newborns. In addition, this study looked at …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #4: Type 1 Diabetes: Insulin Treatment Part 1 of 2
David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be …
Read More »Increased Cancer Risk Associated with Type 1 and Type 2 Diabetes
Why is cancer risk higher among diabetes patients?… Evidence indicates an increased risk of certain cancers among people with type 2 diabetes. Evidence for rarer cancers and for type 1 diabetes is limited. Australian researchers recently explored the excess risk of site-specific cancer incidence and mortality among people with type …
Read More »Keeping Blood Sugars Down May Delay Type 1 Diabetes Complications
Optimum HbA1c level yet to be determined… HbA1c is strongly related to the development of diabetes complications, but it is still controversial as to which HbA1c level to strive for in the treatment of type 1 diabetes. Swedish researchers evaluated HbA1c, followed from diagnosis, as a predictor of severe microvascular …
Read More »Higher Prevalence of Suicide Attempts in Adolescent Type 1 Diabetes Patients
However, advancement in medications and better controlled regimens may be contributing to a decline in psychiatric disorders among this population… We know from previous studies and research that there is a increased risk and prevalence for depression in the diabetic population. Other trials have also linked diabetes with different subtypes …
Read More »Effects of GIP and GLP-1 on Glucagon Response in Type 1 Diabetes
Glucose-dependent insulinotropic polypeptide and glucagon- like peptide-1 have glucose-dependent effects on glucagon secretion but differ in their effects on type 1 and type 2 diabetes patients… From various studies we know that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have glucose-dependent effects on glucagon secretion. GIP causes increased glucagon …
Read More »Type 1 Women Have A 40% Greater Risk of Mortality than Men
In the meta-analysis, women also had twice the excess risk of fatal and nonfatal vascular events, compared with men with type 1 diabetes… Australian researchers have done a meta-analysis to provide reliable estimates of any sex differences in the effect of type 1 diabetes on risk of all-cause mortality and …
Read More »Study Finds Beta Cells Not Completely Lost in Type 1 Patients
Most with long-term diagnosis foud to continue to secrete low levels of insulin… In a large-population based study, researchers used sensitive C-peptide assays to demonstrate that 43-74% people with longstanding (>5 years) type 1 diabetes are microsecretors of endogenous insulin with C-peptide levels. The Scottish researchers measured the occurrence of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.